CRISPR-Cas Spacer Acquisition is a Rare Event in Human Gut Microbiome

Overview

Journal Cell Genom

Date 2024 Dec 25

PMID 39719706

Authors

An-Ni Zhang

Jeffry M Gaston

Pablo Cardenas

Shijie Zhao

Xiaoqiong Gu

Eric J Alm

Affiliations

Soon will be listed here.

Abstract

Host-parasite relationships drive the evolution of both parties. In microbe-phage dynamics, CRISPR functions as an adaptive defense mechanism, updating immunity via spacer acquisition. Here, we investigated these interactions within the human gut microbiome, uncovering low frequencies of spacer acquisition at an average rate of one spacer every ∼2.9 point mutations using isolates' whole genomes and ∼2.7 years using metagenome time series. We identified a highly prevalent CRISPR array in Bifidobacterium longum spreading via horizontal gene transfer (HGT), with six spacers found in various genomic regions in 15 persons from the United States and Europe. These spacers, targeting two prominent Bifidobacterium phages, comprised 76% of spacer occurrence of all spacers targeting these phages in all B. longum populations. This result suggests that HGT of an entire CRISPR-Cas system introduced three times more spacers than local CRISPR-Cas acquisition in B. longum. Overall, our findings identified key ecological and evolutionary factors in prokaryote adaptive immunity.

References

Zhao S, Lieberman T, Poyet M, Kauffman K, Gibbons S, Groussin M . Adaptive Evolution within Gut Microbiomes of Healthy People. Cell Host Microbe. 2019; 25(5):656-667.e8. PMC: 6749991. DOI: 10.1016/j.chom.2019.03.007. View

Heler R, Wright A, Vucelja M, Doudna J, Marraffini L . Spacer Acquisition Rates Determine the Immunological Diversity of the Type II CRISPR-Cas Immune Response. Cell Host Microbe. 2019; 25(2):242-249.e3. PMC: 6640137. DOI: 10.1016/j.chom.2018.12.016. View

Laanto E, Hoikkala V, Ravantti J, Sundberg L . Long-term genomic coevolution of host-parasite interaction in the natural environment. Nat Commun. 2017; 8(1):111. PMC: 5524643. DOI: 10.1038/s41467-017-00158-7. View

Pul U, Wurm R, Arslan Z, Geissen R, Hofmann N, Wagner R . Identification and characterization of E. coli CRISPR-cas promoters and their silencing by H-NS. Mol Microbiol. 2010; 75(6):1495-512. DOI: 10.1111/j.1365-2958.2010.07073.x. View

Langmead B, Salzberg S . Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012; 9(4):357-9. PMC: 3322381. DOI: 10.1038/nmeth.1923. View

Minot S, Sinha R, Chen J, Li H, Keilbaugh S, Wu G . The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 2011; 21(10):1616-25. PMC: 3202279. DOI: 10.1101/gr.122705.111. View

Swarts D, Mosterd C, van Passel M, Brouns S . CRISPR interference directs strand specific spacer acquisition. PLoS One. 2012; 7(4):e35888. PMC: 3338789. DOI: 10.1371/journal.pone.0035888. View

Roux S, Camargo A, Coutinho F, Dabdoub S, Dutilh B, Nayfach S . iPHoP: An integrated machine learning framework to maximize host prediction for metagenome-derived viruses of archaea and bacteria. PLoS Biol. 2023; 21(4):e3002083. PMC: 10155999. DOI: 10.1371/journal.pbio.3002083. View

Westra E, Levin B . It is unclear how important CRISPR-Cas systems are for protecting natural populations of bacteria against infections by mobile genetic elements. Proc Natl Acad Sci U S A. 2020; 117(45):27777-27785. PMC: 7668106. DOI: 10.1073/pnas.1915966117. View

10.

Sun C, Barrangou R, Thomas B, Horvath P, Fremaux C, Banfield J . Phage mutations in response to CRISPR diversification in a bacterial population. Environ Microbiol. 2012; 15(2):463-70. DOI: 10.1111/j.1462-2920.2012.02879.x. View

11.

Goldberg G, Jiang W, Bikard D, Marraffini L . Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting. Nature. 2014; 514(7524):633-7. PMC: 4214910. DOI: 10.1038/nature13637. View

12.

Li R, Fang L, Tan S, Yu M, Li X, He S . Type I CRISPR-Cas targets endogenous genes and regulates virulence to evade mammalian host immunity. Cell Res. 2016; 26(12):1273-1287. PMC: 5143421. DOI: 10.1038/cr.2016.135. View

13.

Cady K, Bondy-Denomy J, Heussler G, Davidson A, OToole G . The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages. J Bacteriol. 2012; 194(21):5728-38. PMC: 3486085. DOI: 10.1128/JB.01184-12. View

14.

Modell J, Jiang W, Marraffini L . CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunity. Nature. 2017; 544(7648):101-104. PMC: 5540373. DOI: 10.1038/nature21719. View

15.

Bolotin A, Quinquis B, Sorokin A, Ehrlich S . Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology (Reading). 2005; 151(Pt 8):2551-2561. DOI: 10.1099/mic.0.28048-0. View

16.

van der Ploeg J . Analysis of CRISPR in Streptococcus mutans suggests frequent occurrence of acquired immunity against infection by M102-like bacteriophages. Microbiology (Reading). 2009; 155(Pt 6):1966-1976. DOI: 10.1099/mic.0.027508-0. View

17.

Mojica F, Diez-Villasenor C, Garcia-Martinez J, Almendros C . Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology (Reading). 2009; 155(Pt 3):733-740. DOI: 10.1099/mic.0.023960-0. View

18.

Minot S, Bryson A, Chehoud C, Wu G, Lewis J, Bushman F . Rapid evolution of the human gut virome. Proc Natl Acad Sci U S A. 2013; 110(30):12450-5. PMC: 3725073. DOI: 10.1073/pnas.1300833110. View

19.

Katoh K, Standley D . MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013; 30(4):772-80. PMC: 3603318. DOI: 10.1093/molbev/mst010. View

20.

Key F, Khadka V, Romo-Gonzalez C, Blake K, Deng L, Lynn T . On-person adaptive evolution of Staphylococcus aureus during treatment for atopic dermatitis. Cell Host Microbe. 2023; 31(4):593-603.e7. PMC: 10263175. DOI: 10.1016/j.chom.2023.03.009. View